skip to primary navigation
skip to content
View menu
Search
Study at Cambridge
About the University
Research at Cambridge
Quick Links
For staff
For alumni
For business
Colleges & departments
Libraries & facilities
Museums & collections
Email & phone search
Site Search
Site Search
Home
Study at Cambridge
Undergraduate
Courses
Applying
Events and open days
Fees and finance
Student blogs and videos
Graduate
Why Cambridge
Qualifications directory
How to apply
Fees and funding
Frequently asked questions
International students
Continuing education
Executive and professional education
Courses in education
About the University
How the University and Colleges work
History
Visiting the University
Term dates and calendars
Map
For media
Video and audio
Find an expert
Publications
International Cambridge
News
Events
Public engagement
Jobs
Giving to Cambridge
Research at Cambridge
For staff
For current students
For alumni
For business
Colleges & departments
Libraries & facilities
Museums & collections
Email & phone search
Home
/
Clinical Neurosciences
/
Cambridge Neuroimmunology
/
Multiple sclerosis research
Home
Cambridge Neuroimmunology
Home
Our Research
Translational Immunology
A trial of a remyelinating drug in multiple sclerosis
SINAPPS2: a clinical trial in psychosis
Antibodies in neurological disease
Autoimmunity in head injury
Our supporters
Our people
Jones group
Coles group
Crisp Group
Joining our groups
Patient and Public Engagement
Work Experience
For patients
General information on MS
Our trials in MS
Our trial in psychosis
Vaculitis, NMO and others
Alemtuzumab
For prescribers
Alemtuzumab Trial Results
History of Alemtuzumab
News
Contact Us
Multiple sclerosis research
